JOYO Pharma

China

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
3 in Phase 3
3 in Phase 2
Next date
SC1011, Phase 2/3 trial completes
Drugs
6
in active trials · 8 in all
Trials
10 active
16 since 2021

Drugs6

DrugHow it worksPartnerStageNext dateDetails
—
Phase 2/3 31 Dec 2026Phase 2/3 trial completes
ROS1 inhibitor
Phase 3 31 Oct 2027Phase 3 trial completes
—
Phase 3 30 Nov 2028Phase 3 trial completes
—
Phase 2 30 Aug 2027Phase 2 trial completes
—
Phase 2 —
—
Phase 2 —

About

No active trial
DC371739, Singletine
SEC filings
None: it does not file with the US SEC
Registry names
2 names in ClinicalTrials.gov
Sources
ClinicalTrials.gov updated 16 Nov 2026 Industry-sponsored drug trials since 2021

Follow JOYO Pharma

Following is part of Solo: you see every change to JOYO Pharma the day it happens.

Solo

$49a month

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in